Physician profile
Daniela Zgherea
NPI 1184818718
$500.24
in general payments reported to CMS, 2019-2025
12 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.41 · 2020: $30.85 · 2022: $137 · 2023: $115 · 2024: $73.86 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $124.33 | 2019-2025 | Fasenra |
| Glaxosmithkline, LLC. | $61.63 | 2020-2025 | Nucala |
| Genzyme Corporation | $54.20 | 2022-2023 | |
| Alcresta Therapeutics, INC. | $46.51 | 2024-2025 | Relizorb |
| Vertex Pharmaceuticals Incorporated | $43.85 | 2023-2025 | Trikafta |
| Amgen INC. | $43.78 | 2023-2025 | Tezspire |
| Baxter Healthcare | $38.49 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System |
| Regeneron Healthcare Solutions, INC. | $28.41 | 2023-2024 | Dupixent |
| Abbvie INC. | $17.04 | 2025 | |
| Electromed, INC. | $15.66 | 2025 | Smartvest |
| Nestle Healthcare Nutrition INC. | $13.88 | 2023 | |
| Philips North America LLC | $12.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniela Zgherea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.